Umgangatho ophezulu wePowder yePeptide 108736-35-2 iLanreotide eFakelwe umfanekiso

Umgangatho ophezulu wePeptide Powder 108736-35-2 Lanreotide

Inkcazelo emfutshane:

Ubunyulu:≧98.0% umgubo omhlophe

Umthamo:5Kgs/ngenyanga

Isatifikethi:COA, HPLC.

Beka ubomi kwishelufa:Iminyaka emi-3

Isicelo:Isetyenziswe kulawulo lwe-acromegaly kunye neempawu ezibangelwa yi-neuroendocrine tumors, ngokukodwa i-carcinoid syndrome

Iqela eliluncedo:Iqela lokuthengisa impahla ngaphandle elinamava kunye noqeqesho lobungcali kumzi-mveliso

Thumela i-imeyile kuthi Khuphela njengePDF

Iinkcukacha zeMveliso

FAQ

Iithegi zeMveliso

Igama lemveliso	ILanreotide
Izithethantonye	I-Angioptin;3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide cyclic (2-7) -disulfide
MOQ	1MG
Inombolo yeCAS.	108736-35-2
Imbonakalo	umgubo omhlophe
Ifomula yeemolekyuli	C₅₄H₆₉N₁₁O₁₀S₂
Ubunzima beMolekyuli	1096.32
Isivavanyi	99%
Isicelo	Ibakala le-Pharma ngenjongo yophando
Ukupakisha	Ngokwesicelo sakho
Ugcino	Londoloza kwizikhongozeli eziqinile, ezikwaziyo ukumelana nokukhanya kwindawo epholileyo
Amagqabantshintshi	NA
Ukudibanisa ngokwezifiso	Iyafumaneka
Supply Ability	1kg/ngenyanga

Ulwazi lweNkampani

√ Amava apheleleyo omaleko wolawulo kumzi-mveliso kunye namagcisa anezakhono abalandeli;
√ Umgangatho usoloko uyingqwalasela yethu ephezulu, inkqubo yeQC eQinisekileyo;
√ Iminyaka eli-11 yamava eqela lokuthengisa kumazwe angaphandle;
√ ilebhu yeR&D eZimeleyo;
√ Iindibano zocweyo zeGMP ezimbini ezityikityiweyo zexesha elide;
√ Imithombo etyebileyo yeefektri ezininzi ezingasebenziyo ukulungiselela iprojekthi elungelelanisiweyo;
√ Iqela elisebenzayo eliSebenzayo ngokuSebenzayo ngendlela engaguqukiyo.
imgsaf